GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JDN who wrote (780)	8/17/1999 11:51:00 AM
From: DanZ	Read Replies (1) of 5582

JDN: Based on your last few posts, your motives are clear. You continue to misrepresent the facts and put a decidedly negative spin on almost everything that you post. The retailers where Zicam was sold in the second quarter have been clearly stated and all sales in Q2 were reorders from the limited retail base in place. None of the new retailers that recently placed orders bought Zicam in the second quarter. These include Walmart, Ride Aid, Target, to name a few. Sales of Zicam in the third quarter should be at least $3.5 million based on filling these stores alone. Your ridicule of Q2 sales of Zicam are without merit. Are you short GUMM by chance? If so, you were suckered by Wexler and have no idea what you are getting yourself into.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next